NR0B1 and type 2 diabetes mellitus: Peroxisome proliferator-activated receptor (PPAR) γ is a member of the nuclear hormone receptor superfamily and the molecular target for the thiazolidinediones (TZD), used clinically to treat insulin resistance in patients with type 2 diabetes.